Rifampin-resistant meningococcal disease

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 977-979

  Rainbow, Jean ^a   Cebelinski, Elizabeth ^a   Bartkus, Joanne ^a   Glennen, Anita ^a   Boxrud, Dave ^a   Lynfield, Ruth ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; MEROPENEM; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; CHILD; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; INFANT; MENINGOCOCCOSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; UNITED STATES;

EID: 19244387492     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1106.050143     Document Type: Article

References (17)

1. Deal WB, Sanders E. Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med. 1969;281:641-5.
2. Weidmer CE, Dunkel TB, Pettyjohn FS, Smith CD, Leibovitz A. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains. J Infect Dis. 1971;124:172-8.
3. Jackson LA, Alexander ER, Debolt CA, Swenson PD, Boase J, McDowell MG, et al. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease. Pediatr Infect Dis J. 1996;15:992-8.
4. Cooke RPD, Riordan T, Jones DM, Painter MJ. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. BMJ. 1989;298:555-8.
5. Yagupsky P, Ashkenazi S, Block C. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis. Lancet. 1993;341:1152-3.
6. Almog R, Block C, Gdalevich M, Lev B, Wiener M, Ashkenazi S. First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin. Infection. 1994;22:69-71.
7. Dawson SJ, Fey RE, McNulty CA. Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains. Commun Dis Public Health. 1999;2:215-6.
8. Cooper ER, Ellison RT, Smith GS, Blaser MJ, Reller LB, Paisley JW. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin. J Pediatr. 1986;108:93-6.
9. Berkey P, Rolston K, Zukiwski A, Gooch G, Bodey GP. Rifampin-resistant meningococcal infection in a patient given rifampin chemoprophylaxis. Am J Infect Control. 1988;16:250-2.
10. Levy DI, del Rio C, Stephens DS. Meningococcemia in identical twins: changes in serum susceptibility after rifampin chemoprophylaxis. J Infect Dis. 1988;157:1064-8.
11. Carter PE, Abadi FJR, Yakubu DE, Pennington TH. Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob Agents Chemother. 1994;38:1256-61.
12. Nolle O. Rifampicin resistance in Neisseria meningitidis; evidence from a study of sibling strains, description of new mutations and notes on population genetics. J Antimicrob Chemother. 1997;39:747-55.
13. Stefanelli P, Fazio C, La Rosa G, Marianelli C, Muscillo M, Mastrantonio P. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother. 2001;47:219-22.
14. National Committee for Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLS1/NCCLS document M100-S15. Wayne (PA): CLSI; 2005.
15. Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B, et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol. 2001;39:75-85.
16. Schultz TR, Tapsall JW, White PA, Newton PJ. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob Agents Chemother. 2000;44:1116.
17. Alcala B, Salcedo C, de la Fuente L, Arreaza L, Uria MJ, Abad R, et al. Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J Antimicrob Chemother. 2004;53:409.